Home / News Details
11/8/21

Humana and Virta Health Team Up to Bring Type 2 Diabetes Reversal Treatment to Humana Employer Group Members

Amid National Diabetes Month, collaboration signals an evolution in diabetes care from traditional disease management to disease reversal

Humana is teaming up with Virta Health to offer a new solution for type 2 diabetes care for Humana Employer Group members. This collaboration is a part of Humana’s ongoing efforts to increase access to care and improve overall health outcomes for members through innovative and digital products. Diabetes continues to be one of the United States’ biggest health concerns. According to the Centers for Disease Control (CDC), more than 34 million people have diabetes, and an estimated 88 million people over the age of 18 have prediabetes.

Beginning in January 2022, Humana will include Virta’s treatment as an option for large, self-funded Employer Groups. The treatment, a first-of-its-kind, is designed to help people reverse their type 2 diabetes through individualized nutritional therapy and continuous remote medical care—allowing patients to achieve normal blood sugar while eliminating the need for diabetes-specific medications. In peer-reviewed clinical trial results of the Virta treatment, 94% of patients who required insulin decreased or eliminated their dosage at one year; 63% of all prescriptions were eliminated at one year (improved to 67% at year two); and patients saw sustained weight loss (an average of 12%).

The CDC states that diabetes is a health condition that affects how the body turns food into energy. With diabetes, the body either doesn’t make enough insulin or can’t use the insulin it makes as well as it should. When there isn’t enough insulin or cells stop responding to insulin, too much blood sugar stays in your bloodstream. Over time, that can cause serious health problems, such as heart disease, vision loss, and kidney disease.

“Humana is committed to bringing evidence-based and cost effective solutions to our members,” said Caleb Gallifant, Vice President, Product and Strategy at Humana. “We must find ways to transform the current treatment paradigm. As diabetes care evolves from management to disease reversal, Humana is excited to offer Virta’s innovative treatment to our members.”

“Our collaboration with Humana, one of the country’s leading health and well-being companies, highlights an increased demand for diabetes reversal as an alternative to traditional management solutions,” said Sami Inkinen, CEO & co-founder of Virta Health. “Ultimately, this allows Virta to help even more patients looking for a way to get off the hamster wheel of more medications, weight gain, side effects, and poor health.”

This collaboration comes at a pivotal moment in diabetes treatment. In August 2021, the American Diabetes Association, the Endocrine Society, the European Association for the Study of Diabetes, and Diabetes UK jointly publishedConsensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.” The report defines diabetes reversal for the first time while refining remission criteria, reflecting the shift toward reversal solutions.

About Virta Health:

Virta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit www.virtahealth.com or follow us on Twitter @virtahealth.

Multimedia Files:

@HumanaNews on Twitter.